Kegiatan Pengabdian Masyarakat dalam Rangka Peningkatan Pemahaman Masyarakat Tentang Penyakit Perlemakan Hati dan Deteksi Dini Penyakit Liver

Authors

  • Shirly Gunawan Universitas Tarumanagara
  • Alicia Sarjuwita Universitas Tarumanagara
  • Vini Claudya Agustine Rajagukguk Universitas Tarumanegara
  • Yohanes Firmansyah Universitas Tarumanagara

DOI:

https://doi.org/10.55606/jpikes.v3i2.1819

Keywords:

education, early detection, fatty liver

Abstract

Non-alcoholic fatty liver disease has become a health problem increasing worldwide. This disease is characterized by excessive fat accumulation in the liver cells unrelated to alcohol consumption. Education and risk factor detection are essential in identifying and preventing the development of this disease. This community service involved 52 respondents at Kalam Kudus II Jakarta High School in May 2023. All participants participated in a series of activities starting from community counseling, disease detection, and education. The results of the medical examination revealed that there were 2 (3.8%) respondents who had increased serum glutamic oxaloacetic transaminase (SGOT)/ serum glutamic pyruvic transaminase (SGPT) levels and 6 (11.5%) had hypercholesterolemia. Education about fatty liver disease can increase public awareness of this condition and promote a healthy lifestyle and good eating habits. Detection of risk factors through laboratory tests such as SGOT, SGPT, bilirubin, and cholesterol is also important in early identification of this disease. In effective fatty liver disease management, it is important to increase awareness of counseling and risk factor detection. Collaborative efforts between medical personnel, health educators, and communities can help reduce the burden of this disease and improve the quality of life of affected individuals.

References

Stefan N, Cusi K. A global view of the interplay between non-alcoholic fatty liver disease and diabetes. lancet Diabetes Endocrinol. 2022;

Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020;158(7):1851–64.

Paik JM, Golabi P, Younossi Y, Srishord M, Mishra A, Younossi ZM. The growing burden of disability related to nonalcoholic fatty liver disease: data from the global burden of disease 2007‐2017. Hepatol Commun. 2020;4(12):1769–80.

Makri E, Goulas A, Polyzos SA. Epidemiology, pathogenesis, diagnosis and emerging treatment of nonalcoholic fatty liver disease. Arch Med Res. 2021;52(1):25–37.

Marjot T, Moolla A, Cobbold JF, Hodson L, Tomlinson JW. Nonalcoholic fatty liver disease in adults: current concepts in etiology, outcomes, and management. Endocr Rev. 2020;41(1):66–117.

Lefere S, Dupont E, De Guchtenaere A, Van Biervliet S, Velde S Vande, Verhelst X, et al. Intensive lifestyle management improves steatosis and fibrosis in pediatric nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2022;20(10):2317–26.

Kwon OY, Choi J, Jang Y. The Effectiveness of eHealth Interventions on Lifestyle Modification in Patients With Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-analysis. J Med Internet Res. 2023;25:e37487.

Augustin S, Ahmed A, Alkhouri N, Canbay A, Corless L, Nakajima A, et al. Identification of patients with advanced fibrosis due to nonalcoholic fatty liver disease: considerations for best practice. J Gastrointest Liver Dis. 2020;29(2):235–45.

Budd J, Cusi K. Nonalcoholic fatty liver disease: what does the primary care physician need to know? Am J Med. 2020;133(5):536–43.

Zheng KI, Fan J-G, Shi J-P, Wong VW-S, Eslam M, George J, et al. From NAFLD to MAFLD: a" redefining" moment for fatty liver disease. Vol. 133, Chinese medical journal. Chinese Medical Journals Publishing House Co., Ltd. 42 Dongsi Xidajie …; 2020. p. 2271–3.

Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346(16):1221–31.

Muthiah MD, Cheng Han N, Sanyal AJ. A clinical overview of non‐alcoholic fatty liver disease: a guide to diagnosis, the clinical features, and complications—what the non‐specialist needs to know. Diabetes, Obes Metab. 2022;24:3–14.

Mantovani A, Scorletti E, Mosca A, Alisi A, Byrne CD, Targher G. Complications, morbidity and mortality of nonalcoholic fatty liver disease. Metabolism. 2020;111:154170.

Downloads

Published

2023-07-29

How to Cite

Shirly Gunawan, Alicia Sarjuwita, Vini Claudya Agustine Rajagukguk, & Yohanes Firmansyah. (2023). Kegiatan Pengabdian Masyarakat dalam Rangka Peningkatan Pemahaman Masyarakat Tentang Penyakit Perlemakan Hati dan Deteksi Dini Penyakit Liver. Jurnal Pengabdian Ilmu Kesehatan, 3(2), 50–59. https://doi.org/10.55606/jpikes.v3i2.1819

Similar Articles

1 2 3 4 5 6 7 > >> 

You may also start an advanced similarity search for this article.